A Stepwise Reduced-Rate Rechallenge Following a Donanemab Infusion-Related Reaction: Real-World Experience (ACAAI 2026) - Oct 28, 2026 - Abstract #M019; Pres time: Nov 13, 2026; 05:35 PM - 06:00 PM; Location: Phoenix Convention Center • North Halls 4–6 (Lower Level); Monitor 1; No abstract available
Clinical • Real-world • Real-world evidence
|